ASCLETIS ANNOUNCES CHINA NATIONAL MEDICAL PRODUCTS ADMINISTRATION ACCEPTANCE OF NEW DRUG APPLICATION FOR DENIFANSTAT (ASC40), A FIRST-IN-CLASS FASN INHIBITOR FOR ACNE TREATMENT

Reuters · 2d ago

Please log in to view news